KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bristol Myers Squibb (BMY) over the last 17 years, with Q2 2025 value amounting to $336.0 million.

  • Bristol Myers Squibb's Gains from Investment Securities changed N/A to $336.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $355.0 million, marking a year-over-year increase of 66349.21%. This contributed to the annual value of -$94.0 million for FY2024, which is 6866.67% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Gains from Investment Securities of $336.0 million as of Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Gains from Investment Securities registered a high of $336.0 million during Q2 2025, and its lowest value of -$510.0 million during Q1 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$27.5 million (2021), whereas its average is -$67.5 million.
  • Over the last 5 years, Bristol Myers Squibb's Gains from Investment Securities had its largest YoY gain of 17250.0% in 2024, and its largest YoY loss of 47500.0% in 2024.
  • Bristol Myers Squibb's Gains from Investment Securities (Quarter) stood at -$32.0 million in 2021, then crashed by 37.5% to -$44.0 million in 2022, then increased by 9.09% to -$40.0 million in 2023, then surged by 172.5% to $29.0 million in 2024, then soared by 1058.62% to $336.0 million in 2025.
  • Its Gains from Investment Securities was $336.0 million in Q2 2025, compared to -$10.0 million in Q1 2025 and $29.0 million in Q4 2024.